公司資料
BioRestorative 股價、新聞與催化劑
- 股票代碼:
- BRTX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.22 USD (-2.40%)
收盤價
最後更新: 2026年8月21日
9.03M USD
市值
股價為何變動
As of Aug 21, 2026, BRTX closed down 2.40% at $0.2153. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
BioRestorative Therapies is a regenerative medicine company focused on cell therapies and musculoskeletal repair. Its business centers on using biologic approaches to address spine and orthopedic conditions.
所在地與產業分類
BioRestorative is headquartered in the United States and listed on NASDAQ. It sits in regenerative medicine and small-cap biotech.
商業模式特徵
The company depends on translational progress, platform validation, and financing to keep development moving. Investors typically watch preclinical or early clinical updates and the company's ability to prove a commercially relevant use case.
生技產業定位
BioRestorative occupies a speculative regenerative-medicine niche within biotech. The stock is driven by platform credibility and the ability to turn cell therapy into a practical treatment path.
未來催化劑
- BioRestorative’s catalysts are regenerative medicine, spinal-disc programs, and any update that shows the platform still has a path. The company remains highly dependent on clinical progress.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。